Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 01 nov 2018 - 14:15
- Statutory name argenx SE
- Title argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition
|201811010000000025_Press Release (PDF).pdf|
Date last update: 14 December 2018